Moximed
Fremont, US · Delaware corporation · 8 known investors
Founders & leadership
AC
Anton CliffordExecutive
JL
James LeechExecutive
CG
Christopher GleasonExecutive
KK
Kevin K. SidowExecutive
Board
JM
Joshua MakowerBoard director
SM

DV
David van MeterBoard director
MM
MW
Michael WassermanBoard director
HA

CS
Christopher ShenBoard director
RK
Robert K. AndersonBoard director
Investors · 8
Lightstone VenturesPortola Valley
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Runway Growth CapitalMenlo Park · $10M – $150M
Advent Life Sciencesreported · 2 sourcesLondonvia Shahzad Malik · board
Future FundreportedLondon
GBS Venture Partners Ltd.reportedMelbourne · $165K – $7.9M
Gilde HealthcarereportedUtrecht · $1.1M – $55M
Vertex Ventures HCreportedSingapore · $500K – $10M
Reported raises · per SEC filings
Form D private placements$132M disclosed across 3 rounds · 2015–2024
▶$62.7MraisedAug 2024 · 35 investors · Other Health CareRule 506(b)
▶$62.7MraisedAug 2024 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David AmersonDirector
- Joshua MakowerDirector
- Shahzad MalikDirector
- David van MeterDirector
- Matt McAvineyDirector
- Anton CliffordExecutive Officer
- James LeechExecutive Officer
- Michael WassermanDirector
- Christopher GleasonExecutive Officer
- Offering amount
- $91M
- Amount sold
- $62.7M
- Minimum investment
- $1
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$49.5MraisedMar 2017 · 8 investors · Other Health CareRule 506(b)
▶$49.5MraisedMar 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Arthur FrankenDirector
- Robert K. AndersonDirector
- Dan MurrayExecutive Officer
- Henry A. PlainDirector
- Robert W. CroceDirector
- Joshua MakowerDirector
- Christopher ShenDirector
- Ryan DrantDirector
- Kevin K. SidowExecutive Officer, Director
- Offering amount
- $51.5M
- Amount sold
- $49.5M
- Minimum investment
- $1
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$19.7MraisedMay 2015 · 104 investors · Other Health CareRule 506(b)
▶$19.7MraisedMay 2015 · 104 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Henry A. PlainDirector
- Christopher ShenDirector
- Kevin K. SidowExecutive Officer, Director
- Robert W. CroceDirector
- Robert K. AndersonDirector
- Arthur FrankenDirector
- Joshua MakowerDirector
- Ryan DrantDirector
- Offering amount
- $37.6M
- Amount sold
- $19.7M
- Minimum investment
- $1
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Moximed for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Moximed's investors?
- Moximed's investors include Lightstone Ventures, New Enterprise Associates (NEA), Runway Growth Capital, Advent Life Sciences, Future Fund, GBS Venture Partners Ltd., Gilde Healthcare, Vertex Ventures HC.
- How much funding has Moximed raised?
- Moximed has disclosed $132M raised across 3 rounds.
- Where is Moximed headquartered?
- Moximed is headquartered in Fremont, US.
